Show simple item record

dc.contributor.authorBuyukcam, Ayse
dc.contributor.authorGuducuoglu, Huseyin
dc.contributor.authorKaraman, Kamuran
dc.contributor.authorGurbuz, Venhar
dc.contributor.authorAliyev, Emil
dc.contributor.authorKara, Ates
dc.contributor.authorCeyhan, Mehmet
dc.date.accessioned2019-12-10T10:39:15Z
dc.date.available2019-12-10T10:39:15Z
dc.date.issued2017
dc.identifier.issn2164-5515
dc.identifier.urihttps://doi.org/10.1080/21645515.2017.1331802
dc.identifier.urihttp://hdl.handle.net/11655/14108
dc.description.abstractInvasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009. We report the first two pediatric cases of invasive pneumococcal infection due to non-vaccine serotype 15A after pneumococcal conjugate vaccine implementation in Turkey. It is essential to monitor the countries' own local seroepidemiologic data for detecting selective pressure of non-vaccine serotypes of S. pneumonia.
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.isversionof10.1080/21645515.2017.1331802
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBiotechnology & Applied Microbiology
dc.subjectImmunology
dc.titleInvasive Pneumococcal Infection Due to Serotype 15A after the Pneumococcal Conjugate Vaccine Implementation in Turkey
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalHuman Vaccines & Immunotherapeutics
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume13
dc.identifier.issue8
dc.identifier.startpage1892
dc.identifier.endpage1894
dc.description.indexWoS


Files in this item

This item appears in the following Collection(s)

Show simple item record